Biotalys NV
Biotalys NV (BTLS.BR) Stock Overview
Explore Biotalys NV’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
196.3M
P/E Ratio
-14.76
EPS (TTM)
$-0.40
ROE
-0.49%
BTLS.BR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Biotalys NV (BTLS.BR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 68.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.08.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.76 and a market capitalization of 196.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
Kevin R. Helash
63
Buchtenstraat 11, Gent
2021